Studiengruppen durch: Im Rahmen des Kompetenznetzes Parkinson wurde im Jahr 2003 die „ German Parkinson Study Group “ (Deutsche Parkinson Studiengruppe) gegründet. Diese wissenschaftlich ausgerichtete Studiengruppe
failure patients through his spin-of biotech company Cardior Pharmaceuticals GmbH (currently a phase II study is running). In 2024, Cardior was acquired by Novo Nordisk for >1 billion EUR. Additionally, Thum
Disputationen im Promotionsverfahren zum Dr. rer. biol. hum.: ► Bing Yang Titel der Dissertation: "Study on traumatic injury pattern and trauma-induced inflammation after experimental trauma modelling" Termin:
children, adolescents, and young adults with differences of sex development (DSD) and their parents: study protocol of Empower-DSD. BMC Endocr Disord 2022;22(1):166. doi: 10.1186/s12902-022-01079-3. Ernst [...] generic transition-oriented patient education program in a multicenter, prospective and controlled study. Journal of Transition Medicine 2018; https://doi.org/10.1515/jtm-2018-0001 (Stand: 03.09.2018) Menrath [...] Eberding A, Müller-Godeffroy E, Szczepanski R, Lange K, Staab D, Thyen U, on behalf of the ModuS Study group. Wie beeinflussen psychosoziale Risiken den Erfolg von Patientenschulungen in der Pädiatrie
hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography-A prospective study. Dig Liver Dis 2011; 43(6): 484-90 Bröcker V, Schwarz A, Becker JU: [BK virus nephropathy after kidney [...] kidney transplantation.] Pathologe 2011; 32(5): 399-405 [German] Choritz H , Büsche G , Kreipe H; Study Group HER2 Monitor: Quality assessment of HER2 testing by monitoring of positivity rates. Virchows [...] Hypothermic circulation arrest with "low flow" lower body perfusion: an experimental feasibility study of microcirculatory parameters. Thorac Cardiovasc Surg 2011; 59(6): 335 - 41 Pincha M, Salguero G
I, Senev A, Van Loon E, Wellekens K, de Vries APJ, Verbeke G, Naesens M. An observational cohort study examined the change point of kidney function stabilization in the initial period after transplantation [...] Gwinner W . Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study. BMC Nephrol . 2020;21:53. DOI: 10.1186/s12882-020-01723-x Scheffner I , Gietzelt M, Abeling T, M
classify the factors influencing mobility re-ported by persons with an amputation: An international study. Prosthet Orthot Int 2017; 41: 412-419 Rollnik JD, Krauss JK, Gutenbrunner C, Wallesch C, Münte T [...] neurological early rehabilitation patients from mechanical ventilation: a retrospective observational study. Eur J Phys Rehabil Med 2017; 53(3): 441-446 Røe C, Kirkevold M, Andelic N, Søberg H, Sveen U, Ba
S. Implementation of the German guideline for work-related medical rehabilitation: A feasibility study. J Rehabil Med 2013;45:965 Bethge M, Löffler S, Schwarz B, Vogel H, Schwarze M, Neuderth S. Implementation [...] outpatient treatment program - Leichter Durch Leben (Light through life) a single-arm follow-up study. Journal of Rehabilitation Medicine 2013; 45: 969-970 Schwarz B, Bethge M, Brandes I, Löffler S, Neuderth
Haumann, H., Freytag, A., Kirsch, C. , Usacheva, S., Wilm, S., Wiese, B., on behalf of the HIOPP-3-iTBX study group (2021). Drug safety for nursing-home residents—findings of a pragmatic, cluster-randomized, [...] safety in nursing home residents: protocol of a cluster randomised controlled trial (HIOPP-3-iTBX study). BMC Geriatrics, 19 , 24. https://doi.org/10.1186/s12877-019-1027-0 Kongressbeiträge Habermann, J
E-cadherin immunohistochemistry in the typing of breast carcinomas: results of a randomized diagnostic study. Histopathology. 83:810 Mouabbi JA, Raghavendra AS, Bassett RL, Jr., Christgen M, Middleton L, Teshome [...] The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combinig static and dynamic biomarker assessments for individualized therapy in early breast [...] Liedtke C, Shak S, Wuerstlein R, Christgen M, Kates RE, Kreipe HH, and Harbeck N (2019). West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles